Network pharmacology integrated molecular docking reveals the bioactive components and potential targets of Morinda officinalis–Lycium barbarum coupled-herbs against oligoasthenozoospermia

Xue Bai(Southwest Medical University), Zhenquan Liu(Beijing University of Chinese Medicine), Yanfei Zheng(Beijing University of Chinese Medicine), Ru Ma(Beijing University of Chinese Medicine), Qiang Li(Chinese Academy of Sciences), Xiaolei Fan(Beijing University of Chinese Medicine), Kailin Zhou(Beijing University of Chinese Medicine), Dan Liu(Machine Intelligence Research Institute), Shuyan Wang(Yunnan Agricultural University), Yibo Tang(Beijing University of Chinese Medicine), Lingru Li(Beijing University of Chinese Medicine), Yafei Chen(Unknown), Guimin Liu(Beijing University of Chinese Medicine)
Scientific Reports
January 26, 2021
10.1038/s41598-020-80780-6
Cited by 34

Related Papers

Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|398
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
|The Lancet|2019|271
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
|Nature Cancer|2023|219
The Role of Chinese Medicine in Health Maintenance and Disease Prevention: Application of Constitution Theory
|The American Journal of Chinese Medicine|2019|169
Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes
|Pharmacological Research|2022|128